<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2526">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 14, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04799691</url>
  </required_header>
  <id_info>
    <org_study_id>2021-CHITS-004</org_study_id>
    <nct_id>NCT04799691</nct_id>
  </id_info>
  <brief_title>Comparison of 2 Ventilatory Support Strategies During Coronavirus Disease 2019 (Covid-19) Pneumonia</brief_title>
  <acronym>STRATIC</acronym>
  <official_title>Comparison of 2 Ventilatory Support Strategies in Patients With Covid-19 Pneumonia Admitted in ICU : Retrospective Monocentric Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This retrospective monocentric study compares 2 ventilatory support strategies on outcomes&#xD;
      (length of stay, intubation, mortality) in patients admitted in Intensive Care Unit with&#xD;
      Covid-19 related pneumonia : invasive strategy used during the first period and non-invasive&#xD;
      strategies (Continuous Positive Airway Pressure, High Flow Nasal Canula, Prone Position) used&#xD;
      during the second period.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Length of stay in ICU</measure>
    <time_frame>At the moment of ICU discharge or death, up to 3 month</time_frame>
    <description>Number of days spent in ICU</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>At the moment of ICU discharge or death, up to 3 month</time_frame>
    <description>Rate of patients alive at the moment of intensive care unit discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>At the moment of ICU discharge or death, up to 3 month</time_frame>
    <description>Number of complications during intensive care unit stay</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">140</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Invasive strategy group</arm_group_label>
    <description>Patients admitted in ICU with Covid-19 related pneumonia during COVID19 first period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-invasive strategy group</arm_group_label>
    <description>Patients admitted in ICU with Covid-19 related pneumonia during COVID19 second period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Invasive ventilation strategy</intervention_name>
    <description>Use of an invasive ventilatory support strategy</description>
    <arm_group_label>Invasive strategy group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Non-invasive ventilation strategies</intervention_name>
    <description>Use of non-invasive ventilatory support strategies</description>
    <arm_group_label>Non-invasive strategy group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with COVID 19 acute hypoxemic respiratory failure admitted in Hospital Sainte&#xD;
        Musse ICU in 2020&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient with confirmed SARS COV2 infection&#xD;
&#xD;
          -  Acute Respiratory Distress Syndrome&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Intensive Care Unit admission for extra pulmonary failure&#xD;
&#xD;
          -  &quot;Do Not Reanimated&quot; order&#xD;
&#xD;
          -  Patient from another Intensive Care Unit&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aude Garnero, MD</last_name>
    <role>Study Director</role>
    <affiliation>Centre Hospitalier Intercommunal Toulon La Seyne sur Mer</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Asmaa Jobic</last_name>
    <phone>04 94 14 55 19</phone>
    <phone_ext>+33</phone_ext>
    <email>asmaa.jobic@ch-toulon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>HÃ´pital Sainte Musse</name>
      <address>
        <city>Toulon</city>
        <state>Var</state>
        <zip>83056</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aude GARNERO, MD</last_name>
      <phone>04 94 14 58 62</phone>
      <phone_ext>+33</phone_ext>
      <email>aude.garnero@ch-toulon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 15, 2021</study_first_submitted>
  <study_first_submitted_qc>March 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 16, 2021</study_first_posted>
  <last_update_submitted>March 18, 2021</last_update_submitted>
  <last_update_submitted_qc>March 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Invasive strategy</keyword>
  <keyword>Non-invasive strategy</keyword>
  <keyword>Continuous Positive Airway Pressure</keyword>
  <keyword>High Flow Nasal Canula</keyword>
  <keyword>Prone position</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

